IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MITOLA, STEFANIA MARIA FILOMENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.491
EU - Europa 9.376
AS - Asia 6.087
SA - Sud America 1.044
AF - Africa 146
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 7
Totale 28.240
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.273
PL - Polonia 5.079
CN - Cina 1.983
SG - Singapore 1.935
IT - Italia 993
BR - Brasile 861
UA - Ucraina 826
DE - Germania 622
VN - Vietnam 607
HK - Hong Kong 581
FI - Finlandia 453
GB - Regno Unito 322
FR - Francia 280
IN - India 195
TR - Turchia 184
RU - Federazione Russa 171
IE - Irlanda 160
BD - Bangladesh 145
CA - Canada 109
ID - Indonesia 103
AU - Australia 83
ES - Italia 76
SE - Svezia 72
NL - Olanda 68
AR - Argentina 67
MX - Messico 63
ZA - Sudafrica 50
IQ - Iraq 49
BE - Belgio 48
CZ - Repubblica Ceca 46
JP - Giappone 44
AT - Austria 31
PK - Pakistan 28
EC - Ecuador 26
VE - Venezuela 23
CL - Cile 21
MA - Marocco 21
SA - Arabia Saudita 20
UZ - Uzbekistan 20
NG - Nigeria 17
AE - Emirati Arabi Uniti 16
CH - Svizzera 16
EG - Egitto 16
TW - Taiwan 16
CO - Colombia 15
GR - Grecia 15
IR - Iran 15
MY - Malesia 15
JO - Giordania 14
KR - Corea 13
DZ - Algeria 12
IL - Israele 12
JM - Giamaica 12
PH - Filippine 12
PY - Paraguay 12
AZ - Azerbaigian 11
KE - Kenya 11
LT - Lituania 11
EE - Estonia 9
BG - Bulgaria 8
HU - Ungheria 8
KG - Kirghizistan 8
NO - Norvegia 8
NP - Nepal 8
AL - Albania 7
EU - Europa 7
KZ - Kazakistan 7
PE - Perù 7
UY - Uruguay 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
HN - Honduras 6
LK - Sri Lanka 6
OM - Oman 6
PA - Panama 6
RO - Romania 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
CR - Costa Rica 5
ET - Etiopia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
BO - Bolivia 4
BY - Bielorussia 4
LA - Repubblica Popolare Democratica del Laos 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
AM - Armenia 3
HR - Croazia 3
LV - Lettonia 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
GT - Guatemala 2
KW - Kuwait 2
LB - Libano 2
MU - Mauritius 2
NI - Nicaragua 2
RS - Serbia 2
SN - Senegal 2
Totale 28.210
Salva come PNG Salva come JPEG
Città #
Warsaw 5.073
Ashburn 1.140
Fairfield 1.087
Singapore 1.043
Woodbridge 719
Houston 685
San Jose 637
Jacksonville 611
Hong Kong 575
Ann Arbor 495
Brescia 463
Seattle 450
Cambridge 421
Beijing 385
Chandler 385
Wilmington 363
Princeton 279
Helsinki 277
New York 273
The Dalles 269
Dong Ket 241
Council Bluffs 231
Los Angeles 218
Nanjing 199
Dearborn 198
Dublin 154
Dallas 144
Lauterbourg 144
Istanbul 141
Munich 120
Ho Chi Minh City 119
Milan 107
São Paulo 102
Buffalo 87
Shanghai 86
Santa Clara 84
Jakarta 81
Nanchang 77
Des Moines 75
San Francisco 74
Hanoi 70
Jinan 70
Chicago 65
Shenyang 65
Changsha 63
Phoenix 63
Turku 60
Hebei 59
Orem 57
Hangzhou 55
Moscow 54
Madrid 51
San Diego 49
London 48
Brussels 46
Redondo Beach 45
Jiaxing 37
Toronto 37
Tianjin 36
Brooklyn 35
Boardman 34
Chennai 34
Guangzhou 34
Tokyo 34
Frankfurt am Main 32
Stockholm 31
Amsterdam 30
Atlanta 30
Kunming 30
Melbourne 30
Johannesburg 29
Montreal 29
Zhengzhou 29
Denver 28
Nuremberg 28
Haikou 27
Porto Alegre 27
Lancaster 26
Lappeenranta 25
Rio de Janeiro 25
Rome 25
Boston 24
Washington 23
Manchester 22
Ningbo 22
Mexico City 21
Poplar 21
Brno 20
Da Nang 20
Curitiba 19
Dhaka 19
Lanzhou 19
San Mateo 19
Ankara 18
Olomouc 18
Tashkent 18
Abuja 17
Belo Horizonte 17
Mumbai 17
Augusta 16
Totale 20.364
Salva come PNG Salva come JPEG
Nome #
Tumor angiogenesis revisited: Regulators and clinical implications 429
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. 397
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 385
Annexin 2A sustains glioblastoma cell dissemination and proliferation. 372
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 356
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 323
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 315
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 313
Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice 307
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 305
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 305
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 301
Claudin3 is localized outside the tight junctions in human carcinomas 293
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 292
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro. 289
Regulation of dendritic cell migration and adaptive immune response by leukotriene b4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function 289
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 286
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 285
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 284
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 283
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 281
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 278
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 277
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 272
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 271
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 271
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 270
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. 266
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 261
Integrins: A flexible platform for endothelial vascular tyrosine kinase receptors. 257
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 255
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 250
Interactions between endothelial cells and HIV-1. 247
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. 247
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 246
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 244
Involvement of chemokine receptor4/ cell-derived factor 1 system during osteosarcoma tumor progression 243
Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. 238
IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. 238
Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. 237
Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. 229
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 229
Nitric oxide modulates the angiogenic phenotype of middle-T transformed endothelial cells. 228
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 227
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 226
Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells. 224
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 220
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivative.Effect on the motility of vascular endothelial cells. 216
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 216
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 216
Preliminary observations on scleral ossicles in performing functionalized 3D vascularized scaffolds for “critical-size” bone defect healing 215
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 211
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 209
Silencing of pantothenate kinase 2 reduces endothelial cell angiogenesis 204
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 202
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 197
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 197
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 195
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 194
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 191
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 186
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 186
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 185
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 185
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 183
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 180
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 176
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 176
Bartonella henselae Persistence within Mesenchymal Stromal Cells Enhances Endothelial Cells Activation and Infectability Amplifying the Angiogenic Process 171
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 164
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 163
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 163
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 163
Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process 162
The Ferritin-Heavy-Polypeptide-Like-17 (FTHL17) gene encodes a ferritin with low stability and no ferroxidase activity and with a partial nuclear localization 160
Insights on the receptor dynamics during the spreading of endothelial cells 160
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 158
Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. 157
Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. 157
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 155
IL-12 regulates an endothelial cell-lymphocyte network: effect on metalloproteinase-9 production. 150
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 148
Evaluation of Paracellular Permeability in VEGFR2 Mutants Patient-Derived Organoid 148
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 146
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 146
Simulation of VEGF receptor recruitment on ECs membrane 146
CCL16 activates an angiogenic program in vascular endothelial cells 145
Vascular disrupting activity of combretastatin analogues 145
Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production. 144
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 144
Fibroblast growth factor-2 in angiogenesis 143
Gremlin as a novel pro-angiogenic VEGFR2 agonist: production of a biologically active recombinant form in S2 Drosophila cells 142
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 142
A mechano-biological model of the coupling between cellular con- tractility and VEGFR2/VEGF interactions. 142
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 139
Dendritic cell-endothelial cell cross-talk in angiogenesis. 138
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 138
Role of VEGFs in metabolic disorders 137
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 136
Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels 135
Totale 22.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021314 0 0 0 0 0 0 0 0 0 0 0 314
2021/20221.291 81 244 27 28 37 69 74 72 67 176 103 313
2022/20231.191 198 78 61 69 90 276 22 103 166 15 42 71
2023/20241.607 85 71 154 124 91 243 60 101 295 119 40 224
2024/20253.248 69 25 38 485 363 252 291 141 394 200 572 418
2025/20267.816 650 851 527 1.002 759 535 1.253 372 575 759 401 132
Totale 28.615